Efficacy of immune checkpoint inhibitors in different types of melanoma
Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune chec...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Taylor & Francis Group
2021-01-01
|
| Rangatū: | Human Vaccines & Immunotherapeutics |
| Ngā marau: | |
| Urunga tuihono: | http://dx.doi.org/10.1080/21645515.2020.1771986 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|